OVERVIEW
During the forecast period 2019-2024, the global biobanks market is expected to post a CAGR of nearly 9.2%. The study’s base year is 2018. This is primarily attributable to the increasing number of biobanks and the increasing number of biosamples around the world, resulting in high demand for equipment.
TABLE OF CONTENT
1 Global Biobanking Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Biobanking Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Biobanking Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Biobanking Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Biobanking Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Biobanking Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Biobanking Market – By Product & Service (Market Size – & million/billion)
8.1 Equipment
8.2 Consumables
8.3 Services
8.4 Software
9 Global Biobanking Market – By Sample Type
9.1 Blood Products
9.2 Human Tissues
9.3 Nucleic Acids
9.4 Biological Fluids
9.5 Human Waste Products
10 Global Biobanking Market – By Application
10.1 Regenerative Medicine
10.2 Life Science Research
10.3 Clinical Research
11 Global Biobanking Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Biobanking Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Biobanking Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific Inc.
13.3 Panasonic Healthcare Holdings Co., Ltd.
13.4 Becton, Dickinson and Company
13.5 Brooks Automation, Inc.
13.6 Chart Industries, Inc.
13.7 Hamilton Company
13.8 Qiagen N.V.
13.9 Tecan Trading AG
13.10 Merck KGaA
13.11 VWR Corporation
13.12 Company 11 & more
14 Global Biobanking Market – Appendix
14.1 Sources
14.2 Abbreviations